Literature DB >> 3007796

Relationship between the myofibrillar ATPase activity of human biopsy material and hemodynamic parameters.

N Takeda, H Rupp, G Fenchel, H E Hoffmeister, R Jacob.   

Abstract

The myofibrillar ATPase activity and pyrophosphate gel electrophoretic pattern of native myosin of fresh human left ventricular papillary muscles were examined in 52 cases of mitral valve replacement. The myofibrillar ATPase activity of hypertrophied myocardium did not differ from that of non-hypertrophied myocardium (mean +/- SD, 36.2 +/- 8.7 vs 31.8 +/- 8.6 nmolPi/mg/min, ns) and there was no significant difference in myofibrillar ATPase activity as a function of left ventricular enddiastolic pressure. Pyrophosphate gel electrophoresis of myosin revealed the presence of two components. It is questionable whether the component of higher electrophoretic mobility (approximately 25-35% in concentration) is identical with rat ventricular myosin VM-1 because an increase in this component seems to correlate with a decrease of myofibrillar ATPase activity, its concentration was significantly higher in the hearts with left ventricular hypertrophy, high enddiastolic pressure, high aortic pressure or low cardiac index. From these results, it is not necessarily clear whether hemodynamic overload in valvular heart diseases can alter left ventricular myofibrillar ATPase activity, but it can be said that the overload influences the concentration of the two components of native myosin revealed by pyrophosphate gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3007796     DOI: 10.1536/ihj.26.909

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  3 in total

1.  Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

Authors:  B D Lowes; W Minobe; W T Abraham; M N Rizeq; T J Bohlmeyer; R A Quaife; R L Roden; D L Dutcher; A D Robertson; N F Voelkel; D B Badesch; B M Groves; E M Gilbert; M R Bristow
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

2.  Reduced cardiac myofibrillar Mg-ATPase activity without changes in myosin isozymes in patients with end-stage heart failure.

Authors:  A A Alousi; A M Grant; J R Etzler; B R Cofer; J Van der Bel-Kahn; D Melvin
Journal:  Mol Cell Biochem       Date:  1990-07-17       Impact factor: 3.396

3.  Differences between atrial and ventricular protein profiling in children with congenital heart disease.

Authors:  V Pelouch; M Milerová; B Ostádal; B Hucín; M Samánek
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.